Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

News Focus

Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)

Bullboard - Stock Discussion Forum Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the... see more

Add To Watchlist

Bullboard (NDAQ:LEXX)

View:

(0)
•••

Post by PressReleaseon Aug 11, 2022 8:30am

New Press Release - Lexaria Bioscience Corp. (NASDAQ: LEXX) Focused on Filling Need for Hypertension Treatment Solution

NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “The Power of Science to Stop a Killer.”To hear the AudioPressRelease, please visit: The NetworkNewsAudio News PodcastTo view the full editorial...read article.

(0)
•••

Post by PressReleaseon Aug 10, 2022 8:15am

New Press Release - Lexaria Announces Positive Feedback from Pre-IND Meeting with FDA on DehydraTECH-CBD for Hypertension

Significant Milestone Achieved in Commercial Product Development ProgramAbbreviated 505(b)(2) Strategy Confirmed as an Appropriate NDA PathwayKELOWNA, BC / ACCESSWIRE / August 10, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug...read article.

NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets

posted Nov 14, 2024 9:00am by NurExone Biologic Inc.

“We are honored by the EMA’s recognition of ExoPTEN through the Orphan Medicinal Product Designation, which significantly advances our ability to enter the European market and offers hope to those impacted by acute spinal cord injuries,” said Dr. Lior Shaltiel, Chief Executive Officer of NurExone. “This designation, together with the ...read more

(0)
•••

Post by PressReleaseon Aug 09, 2022 8:30am

New Press Release - Lexaria Bioscience Corp. (NASDAQ: LEXX) Developing Powerful Tech to Treat Hypertension

NEW YORK, Aug. 09, 2022 (GLOBE NEWSWIRE) -- via InvestorWire — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and...read article.

(0)
•••

Post by PressReleaseon Jul 27, 2022 1:17pm

New Press Release - Lexaria's DehydraTECH-CBD Hypertension Study HYPER-H21-4 Dosing Complete with No Serious Adverse Events

KELOWNA, BC / ACCESSWIRE / July 27, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce that dosing with Lexaria's DehydraTECH™-processed cannabidiol ("DehydraTECH-CBD") has been completed...read article.

(0)
•••

Post by PressReleaseon Jul 27, 2022 9:11am

New Press Release - Lexarias DehydraTECH-CBD Hypertension Study HYPER-H21-4 Dosing Complete with No Serious Adverse Events

(TheNewswire)Kelowna, British Columbia – TheNewswire - July 27, 2022 –Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms is pleased to announce that dosing with Lexaria’s DehydraTECH™-processed cannabidiol...read article.

(0)
•••

Post by PressReleaseon Jul 26, 2022 9:06am

New Press Release - Lexaria's Licensee Premier Wellness Science Co., Ltd. Launches New Brand in Preparation to Deploy DehydraTECH CBD Products in Japan

(TheNewswire)Kelowna, British Columbia – TheNewswire - July 26, 2022 – Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms is pleased to announce that its exclusive* Japanese Licensee, Premier Wellness Science Co., Ltd....read article.

Comment by shawkon Jul 24, 2022 9:29pm

RE:Lexaria team

https://4495825a-d729-4d8f-ade8-e78f828e1c8d.usrfiles.com/ugd/449582_fb7fedcba9454f1ab1fd34375f292bc0.pdf I had a chance to chat with Chris Bunka, CEO of Lexaria Bioscience (NASDAQ: LEXX) (NASDAQ ...more

176

Discussion

Post by shawkon Jul 24, 2022 9:24pm

Oral Cannabidiol Effect on Blood Pressure in Hypertensive Pa

https://clinicaltrials.gov/ct2/show/NCT05346562

162

Post by DehydraTECHon Jul 23, 2022 2:52pm

Lexaria team

Did a 3 week 4 country European tour with big pharma anybody know if they signed up new major deals

214

Discussion

Comment by WakeUPPon Jul 18, 2022 2:01pm

RE:RE:Ted Ohashi

he liked TGIFF at .40 too lol roflmao

Discussion

Comment by WakeUPPon Jul 18, 2022 1:57pm

RE:Ted Ohashi

Ohashi also pumps TGIFF, .02 and and KHRN at .13 and other LOSERS now you are excited he llikes lEXX??????? are you THAT DUMB?????? do you LIKE losing?????????????

Discussion

Post by shawkon Jul 18, 2022 1:19pm

Ted Ohashi

1. Lexaria has been notified of the allowance of its 26th worldwide patent to be granted in Japan. Entitled Lipophilic Active Agent Infused Compositions With Reduced Food Effect, the patent recognizes ...more

185

Discussion

Post by WakeUPPon Jul 18, 2022 11:53am

hey ag

How is hangin with the twitter pumpers going for ya? big win there, but on how many shares? lookin back, you made HuNdReds on that one wow Now, HOW MCUH have you LOST on loser after loser after ...more

101

Comment by WakeUPPon Jul 15, 2022 9:37am

RE:Fins on sedar

hahhaaha they dont read financials they read STOCK PROMO and post woooohoo we plan to start a trial, we got a patent in austalia that dont pay us antyhting, we have (or used to have) a deal with ...more

Discussion

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

< Previous

Next >

Dealroom for high-potential pre-IPO opportunities

Become a member today, It's free!

Bullboard - Stock Discussion Forum Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Bullboard (NDAQ:LEXX)

New Press Release - Lexaria Bioscience Corp. (NASDAQ: LEXX) Focused on Filling Need for Hypertension Treatment Solution

New Press Release - Lexaria Announces Positive Feedback from Pre-IND Meeting with FDA on DehydraTECH-CBD for Hypertension

NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets

New Press Release - Lexaria Bioscience Corp. (NASDAQ: LEXX) Developing Powerful Tech to Treat Hypertension

New Press Release - Lexaria's DehydraTECH-CBD Hypertension Study HYPER-H21-4 Dosing Complete with No Serious Adverse Events

New Press Release - Lexarias DehydraTECH-CBD Hypertension Study HYPER-H21-4 Dosing Complete with No Serious Adverse Events

New Press Release - Lexaria's Licensee Premier Wellness Science Co., Ltd. Launches New Brand in Preparation to Deploy DehydraTECH CBD Products in Japan

RE:Lexaria team

Oral Cannabidiol Effect on Blood Pressure in Hypertensive Pa

Lexaria team

RE:RE:Ted Ohashi

RE:Ted Ohashi

Ted Ohashi

hey ag

RE:Fins on sedar

Featured News Links

This $10M Deal Could Reshape the Future of Global Creator Platforms

Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits

Explained: The Psychology of Options Trading with Practical Tips

Meet the Top 5 Best Online Brokerages in Canada

New Gold and Copper Hotspot Identified – What’s Next for This Serbian Project?

Major Funding Secured! Company Closes First Round of Private Placement

Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.

Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023

Gold, growth and sustainability in focus for this resource company

Star Diamond Corporation Announces Third Quarter 2024 Results

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard - Stock Discussion Forum Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Join the community and start posting on the bullboards today. It's free.

Create a portfolio watchlist today. It's free.

Bullboard (NDAQ:LEXX)

Featured News Links